首页> 外文期刊>Advances in Radiation Oncology >Report of the First Patient Treated for Pelvic Sarcoma With a Directional 103Pd Brachytherapy Device
【24h】

Report of the First Patient Treated for Pelvic Sarcoma With a Directional 103Pd Brachytherapy Device

机译:首例采用定向 103 Pd近距离放射治疗仪治疗盆腔肉瘤的患者的报告

获取原文
       

摘要

Sarcomas are rare malignant tumors of mesenchymalorigin with 80% originating from soft tissue.1 The majority of soft tissue sarcomas occur in the extremities;nevertheless, 10% to 15% occur in the retroperitoneum orpelvis and are usually advanced at time of diagnosis.2Oncologic resection with or without perioperative radiation therapy has become the cornerstone for successfultreatment.3-5 The goal of surgery is complete resection with negative margins (R0 resection). When not possible,either preoperative or postoperative radiation therapy isrecommended.6-9 Technical challenges related toanatomic complexities and large tumor size at diagnosisof most pelvic and retroperitoneal sarcomas often lead tomicroscopically positive margins (R1 resection) associated with high risk of local recurrence.2,10-13 Deliveringadequate doses of radiation in the postoperative settingrepresents a significant treatment challenge, especially insoft tissue sarcomas located in the abdomen, retroperitoneum, or pelvic regions.14 In these cases, localcontrol with preoperative and intraoperative radiationtherapy (IORT) are important considerations.
机译:肉瘤是间质性马来酸的罕见恶性肿瘤,其中80%起源于软组织。1大多数软组织肉瘤发生在四肢;然而,腹膜后或骨盆发生在10%至15%,通常在诊断时就已进展。2肿瘤切除术伴或不伴围手术期放射治疗已成为成功治疗的基础。3-5手术的目标是切缘阴性的完全切除(R0切除)。在不可能的情况下,建议进行术前或术后放疗。6-9在诊断大多数盆腔和腹膜后肉瘤时,与解剖学复杂性和较大的肿瘤大小相关的技术挑战通常导致镜检阳性切缘(R1切除)与局部复发的高风险相关。2, 10-13在术后环境中提供足够剂量的放射线是一个重大的治疗挑战,尤其是位于腹部,腹膜后或骨盆区域的软组织肉瘤。14在这些情况下,术前和术中放疗(IORT)进行局部控制是重要的考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号